Venn Life Sciences Share News (VENN)
VENN Share
VENN Share
VENN Share
VENN Share
VENN
VENN Share
VENN Broker
VENN Directors
VENN Financial
VENN
VENN Short
VENNMon, 30th Jul 2018 16:11
LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Monday that Spreadex Ltd held a 5.5% stake in the drug developer after a Tuesday transaction.
Through a combination of contracts for difference and ordinary shares, Spreadex's holding was 3.9 million shares. Its previous holding in Venn, if any, has not been disclosed.
Shares in Venn Life Sciences were down 1.2% at 6.18 pence on Monday.
Clinical research and development group Venn Life Sciences Holdings has confirmed Jonathan Hartshorn has begun his tenure as the group's new chief financial officer. The London-listed company had appointed Hartshorn, who left his role as head of finance for the onshore division of Mainstream Renewab
Read more